sun2 Search Results


93
Atlas Antibodies hpa001209
Hpa001209, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/Anti-SUN2/pm24950247-53-26-27
Average 93 stars, based on 1 article reviews
hpa001209 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti sun2
Anti Sun2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/SUN2+Antibody/pmc09079088-42-16-19
Average 93 stars, based on 1 article reviews
anti sun2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
OriGene sun2 nm 001199579 human tagged orf
Fig. 1 | SUN1/2 depletion alters nuclear mor- phology. a Representative images of MSCs treated with siRNA targeting SUN1/2 (siSUN) which were stained for SUN1 (green), <t>SUN2</t> (red), and DNA (blue). b siSUN-treated cells had 47% decrease of SUN1 intensity (n = 1478, P < 0.0001). c SUN2 intensity levels were decreased by 52% in siSUN- treated cells (n = 1478, P < 0.0001). d MSCs treated with siSUN had an increase in nuclear area by 7% (n = 1478, p 0 < 0.01). e Nucleus perimeter decreased in siSUN-treated MSCs by 8% (n = 1478, p < 0.0001). f Nuclear circularity decreased by 9% in siSUN-treated cells (n = 1478, p < 0.001). Compar- isons were made against control using non- parametric Mann–Whitney test where *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The scale bar represents 50 μm. Results were presented as mean ± STD.
Sun2 Nm 001199579 Human Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/SUN2+(NM_001199579)+Human+Tagged+ORF+Clone/pm40082539-244-11-17
Average 93 stars, based on 1 article reviews
sun2 nm 001199579 human tagged orf - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech rabbit polyclonal antibodies against sun2
Fig. 1. Characterization of <t>SUN2-AS1.</t> (A) A schematic representation of human SUN2-AS1 transcribed from the antisense strand of the protein-coding gene SUN2 on chromosome 22. (B) 5′- and 3′ RACE was conducted to determine the full length of SUN2-AS1. Full-length SUN2-AS1 was chemically synthesized and cloned into the pcDNA3.1(+) vector. Total RNA from ZIKV-infected A549 cells was extracted at 24 h.p.i. The RNA was then reverse transcribed and amplified using the SMARTer RACE cDNA amplification kit. (C) The CPAT (Coding Potential Assessment Tool) was used to predict the coding probability of SUN2-AS1. (D) 293T cells were transfected with pcDNA3.1-GFP-HA (vector control), SUN2-HA (positive control), pcDNA3.1-HA-SUN2-AS1, or pcDNA3.1-SUN2-AS1-HA plasmid. At 36 h post- transfection, cells were harvested for a Western blot analysis to detect anti-HA bands. Blots were representative of at three independent experiments. (E) The relative expression of human β-actin (cytoplasmic control), U6 (nuclear control), and the expression of SUN2-AS1 were analyzed by using qRT-PCR in the nuclear and cytoplasmic fractions.
Rabbit Polyclonal Antibodies Against Sun2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/SUN2+Antibody/pm39288611-69-18-23
Average 93 stars, based on 1 article reviews
rabbit polyclonal antibodies against sun2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
OriGene mouse sun2
Fig. 1. Characterization of <t>SUN2-AS1.</t> (A) A schematic representation of human SUN2-AS1 transcribed from the antisense strand of the protein-coding gene SUN2 on chromosome 22. (B) 5′- and 3′ RACE was conducted to determine the full length of SUN2-AS1. Full-length SUN2-AS1 was chemically synthesized and cloned into the pcDNA3.1(+) vector. Total RNA from ZIKV-infected A549 cells was extracted at 24 h.p.i. The RNA was then reverse transcribed and amplified using the SMARTer RACE cDNA amplification kit. (C) The CPAT (Coding Potential Assessment Tool) was used to predict the coding probability of SUN2-AS1. (D) 293T cells were transfected with pcDNA3.1-GFP-HA (vector control), SUN2-HA (positive control), pcDNA3.1-HA-SUN2-AS1, or pcDNA3.1-SUN2-AS1-HA plasmid. At 36 h post- transfection, cells were harvested for a Western blot analysis to detect anti-HA bands. Blots were representative of at three independent experiments. (E) The relative expression of human β-actin (cytoplasmic control), U6 (nuclear control), and the expression of SUN2-AS1 were analyzed by using qRT-PCR in the nuclear and cytoplasmic fractions.
Mouse Sun2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/Sun2+(NM_001205346)+Mouse+Tagged+ORF+Clone/pm33686165-194-10-15
Average 90 stars, based on 1 article reviews
mouse sun2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
OriGene myc tagged mouse sun2
Figure 6. Working model for the regulation of the Golgi organization by LINC complex. Left, The minus-end- directed MT motor activity, i.e., dynein (blue), dominates plus-end-directed motor activity under a steady-state condition, and juxtanuclear accumulation of the Golgi complex is observed. Right, In SUN1-depleted cells, KIF20A is activated or suppression of KIF20A activity is cancelled, and KIF20A activity dominates dynein activity. An explanation for the inhibition of KIF20A activity in the presence of SUN1 is that LINC complex formations are biased towards SUN1 inclusion and <t>SUN2/nesprin-2</t> LINC complex formation is suppressed. In response to SUN1 depletion, incorporation of nesprin-2 in the SUN1-LINC complex decreased and SUN2/ nesprin-2 LINC complexes are formed. As a result, functions of KIF20A acting with a SUN2/nesprin-2 LINC complex becomes predominant (orange) over the minus-end-directed motor activities (blue), and the Golgi complex is dispersed.
Myc Tagged Mouse Sun2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/Sun2+(NM_001205345)+Mouse+Tagged+ORF+Clone/pm33686165-194-9-15
Average 90 stars, based on 1 article reviews
myc tagged mouse sun2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
OriGene sun2 tf300646a fi302577 hush 29 shrna constructs
<t>SUN2</t> oligomerization in the NE. (A) Constructs used in this figure. (B) Represent­ative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–E) Plots of b vs. N for the indicated constructs. The data in C were fitted to a monomer/dimer/trimer binding model (solid red line), which is shown in D and E (dashed red line), with K MD = 4100 (1000 μM) , K DT = 0.06 (0.01 μM) , and a monomer/trimer binding model (solid green line) with K MT = 26 (6 μM) ± 7.
Sun2 Tf300646a Fi302577 Hush 29 Shrna Constructs, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/SUN2+Human+shRNA+Plasmid+Kit/pmc05921568-164-5-15
Average 90 stars, based on 1 article reviews
sun2 tf300646a fi302577 hush 29 shrna constructs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

91
Thermo Fisher gene exp sun2 rn01505183 m1
<t>SUN2</t> oligomerization in the NE. (A) Constructs used in this figure. (B) Represent­ative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–E) Plots of b vs. N for the indicated constructs. The data in C were fitted to a monomer/dimer/trimer binding model (solid red line), which is shown in D and E (dashed red line), with K MD = 4100 (1000 μM) , K DT = 0.06 (0.01 μM) , and a monomer/trimer binding model (solid green line) with K MT = 26 (6 μM) ± 7.
Gene Exp Sun2 Rn01505183 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/Gene+Exp%2E+Sun2%2C+Rn01505183_m1/pm36322767-204-24-11
Average 91 stars, based on 1 article reviews
gene exp sun2 rn01505183 m1 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

91
Thermo Fisher gene exp sun2 hs00391446 m1
( A ) Protein expression of DNAJB1-PRKACA (DP) is detected with a protein kinase A catalytic α subunit (PKA) antibody. WT PKAc, DP major, and DP minor are identified. Lane 1, FLC-H cell line; lane 2, nonmalignant liver; lane 3, FLC patient sample; lane 4, FLC PDX sample. Vinculin expression for loading control is shown in the lower panel. Uncropped immunoblot shown in , A and B. ( B ) qPCR showing the RQV of miR-10b in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA or scrambled sequence compared with mock ( n = 4 each condition). ( C ) Luciferase signal (RLU) in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment is shown as RQV compared with the scrambled negative control (6 trials, n = 6 each condition). ( D ) qPCR showing the RQV of FANCC , KLF11 , SEC14L2 , SIRT5 , <t>SUN2</t> , and TRIM35 in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment compared with the negative control ( n = 5–7 trials with 3 replicates for each condition, SIRT5 n = 2 trials). ( E ) Soft agar colony formation of FLC-H cells 35 days after 500 nM miR-10b LNA compared with the negative control shown as RQV. ( F ) Representative nitro blue tetrazolium–stained images shown (2 trials, n = 8 each condition). ( G ) EdU incorporation in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA compared with the negative control shown as RQV (2 trials, n = 6 each condition). ( H ) Representative DAPI- and EdU-stained images show total and proliferative cells, respectively. Scale bars: 100 μm. In all assays, each dot represents the average signal across technical replicates for a single biological replicate. P values are calculated by 2-tailed Student’s t test. P values reported in B and D were adjusted for multiple testing correction post hoc by the Benjamini-Hochberg method.
Gene Exp Sun2 Hs00391446 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/Gene+Exp%2E+SUN2%2C+Hs00391446_m1/pmc09220943-224-28-36
Average 91 stars, based on 1 article reviews
gene exp sun2 hs00391446 m1 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

90
Merck KGaA sun2 mabt880 antibody
( A ) Protein expression of DNAJB1-PRKACA (DP) is detected with a protein kinase A catalytic α subunit (PKA) antibody. WT PKAc, DP major, and DP minor are identified. Lane 1, FLC-H cell line; lane 2, nonmalignant liver; lane 3, FLC patient sample; lane 4, FLC PDX sample. Vinculin expression for loading control is shown in the lower panel. Uncropped immunoblot shown in , A and B. ( B ) qPCR showing the RQV of miR-10b in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA or scrambled sequence compared with mock ( n = 4 each condition). ( C ) Luciferase signal (RLU) in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment is shown as RQV compared with the scrambled negative control (6 trials, n = 6 each condition). ( D ) qPCR showing the RQV of FANCC , KLF11 , SEC14L2 , SIRT5 , <t>SUN2</t> , and TRIM35 in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment compared with the negative control ( n = 5–7 trials with 3 replicates for each condition, SIRT5 n = 2 trials). ( E ) Soft agar colony formation of FLC-H cells 35 days after 500 nM miR-10b LNA compared with the negative control shown as RQV. ( F ) Representative nitro blue tetrazolium–stained images shown (2 trials, n = 8 each condition). ( G ) EdU incorporation in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA compared with the negative control shown as RQV (2 trials, n = 6 each condition). ( H ) Representative DAPI- and EdU-stained images show total and proliferative cells, respectively. Scale bars: 100 μm. In all assays, each dot represents the average signal across technical replicates for a single biological replicate. P values are calculated by 2-tailed Student’s t test. P values reported in B and D were adjusted for multiple testing correction post hoc by the Benjamini-Hochberg method.
Sun2 Mabt880 Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/anti+sun2/pmc11178842-261-77-79
Average 90 stars, based on 1 article reviews
sun2 mabt880 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GeneTex rabbit anti-sun2
The LINC complex is absent from chromatin hernia. Representative images of U2OS GFP-NLS shLmnB1 cells arrested with thymidine, fixed, and labeled with LmnA antibodies (top three rows, rabbit; bottom, mouse) and (from top to bottom) Sun1, <t>Sun2,</t> nesprin1 (Nsp1), and nesprin2 (Nsp2) antibodies. Bars, 10 µm.
Rabbit Anti Sun2, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/rabbit+anti+sun2+epr6557/pmc05057282-142-21-24
Average 90 stars, based on 1 article reviews
rabbit anti-sun2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GenScript corporation mp029-cry2-mcherry-sun2-c variant
The LINC complex is absent from chromatin hernia. Representative images of U2OS GFP-NLS shLmnB1 cells arrested with thymidine, fixed, and labeled with LmnA antibodies (top three rows, rabbit; bottom, mouse) and (from top to bottom) Sun1, <t>Sun2,</t> nesprin1 (Nsp1), and nesprin2 (Nsp2) antibodies. Bars, 10 µm.
Mp029 Cry2 Mcherry Sun2 C Variant, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sun2/mp029+cry2+mcherry+sun2+c+variant/pm37295473-233-0-18
Average 90 stars, based on 1 article reviews
mp029-cry2-mcherry-sun2-c variant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 | SUN1/2 depletion alters nuclear mor- phology. a Representative images of MSCs treated with siRNA targeting SUN1/2 (siSUN) which were stained for SUN1 (green), SUN2 (red), and DNA (blue). b siSUN-treated cells had 47% decrease of SUN1 intensity (n = 1478, P < 0.0001). c SUN2 intensity levels were decreased by 52% in siSUN- treated cells (n = 1478, P < 0.0001). d MSCs treated with siSUN had an increase in nuclear area by 7% (n = 1478, p 0 < 0.01). e Nucleus perimeter decreased in siSUN-treated MSCs by 8% (n = 1478, p < 0.0001). f Nuclear circularity decreased by 9% in siSUN-treated cells (n = 1478, p < 0.001). Compar- isons were made against control using non- parametric Mann–Whitney test where *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The scale bar represents 50 μm. Results were presented as mean ± STD.

Journal: Communications biology

Article Title: Depletion of SUN1/2 induces heterochromatin accrual in mesenchymal stem cells during adipogenesis.

doi: 10.1038/s42003-025-07832-3

Figure Lengend Snippet: Fig. 1 | SUN1/2 depletion alters nuclear mor- phology. a Representative images of MSCs treated with siRNA targeting SUN1/2 (siSUN) which were stained for SUN1 (green), SUN2 (red), and DNA (blue). b siSUN-treated cells had 47% decrease of SUN1 intensity (n = 1478, P < 0.0001). c SUN2 intensity levels were decreased by 52% in siSUN- treated cells (n = 1478, P < 0.0001). d MSCs treated with siSUN had an increase in nuclear area by 7% (n = 1478, p 0 < 0.01). e Nucleus perimeter decreased in siSUN-treated MSCs by 8% (n = 1478, p < 0.0001). f Nuclear circularity decreased by 9% in siSUN-treated cells (n = 1478, p < 0.001). Compar- isons were made against control using non- parametric Mann–Whitney test where *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The scale bar represents 50 μm. Results were presented as mean ± STD.

Article Snippet: The plasmids used for the knockdown-rescue experiments are: pEGFP-SUN1_785 (Addgene 125852), SUN2 (NM_001199579) Human Tagged ORF Clone (Origene RC234801), and pCMV6-Entry (OriGene PS100001) as the empty vector control. qPCR About 2 ul of each CUT&RUN sample was run in a 20 ul reaction following Bio-Rad protocols targeting Adipoq (Bio-Rad, 10025636).

Techniques: Staining, Control, MANN-WHITNEY

Fig. 1. Characterization of SUN2-AS1. (A) A schematic representation of human SUN2-AS1 transcribed from the antisense strand of the protein-coding gene SUN2 on chromosome 22. (B) 5′- and 3′ RACE was conducted to determine the full length of SUN2-AS1. Full-length SUN2-AS1 was chemically synthesized and cloned into the pcDNA3.1(+) vector. Total RNA from ZIKV-infected A549 cells was extracted at 24 h.p.i. The RNA was then reverse transcribed and amplified using the SMARTer RACE cDNA amplification kit. (C) The CPAT (Coding Potential Assessment Tool) was used to predict the coding probability of SUN2-AS1. (D) 293T cells were transfected with pcDNA3.1-GFP-HA (vector control), SUN2-HA (positive control), pcDNA3.1-HA-SUN2-AS1, or pcDNA3.1-SUN2-AS1-HA plasmid. At 36 h post- transfection, cells were harvested for a Western blot analysis to detect anti-HA bands. Blots were representative of at three independent experiments. (E) The relative expression of human β-actin (cytoplasmic control), U6 (nuclear control), and the expression of SUN2-AS1 were analyzed by using qRT-PCR in the nuclear and cytoplasmic fractions.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 1. Characterization of SUN2-AS1. (A) A schematic representation of human SUN2-AS1 transcribed from the antisense strand of the protein-coding gene SUN2 on chromosome 22. (B) 5′- and 3′ RACE was conducted to determine the full length of SUN2-AS1. Full-length SUN2-AS1 was chemically synthesized and cloned into the pcDNA3.1(+) vector. Total RNA from ZIKV-infected A549 cells was extracted at 24 h.p.i. The RNA was then reverse transcribed and amplified using the SMARTer RACE cDNA amplification kit. (C) The CPAT (Coding Potential Assessment Tool) was used to predict the coding probability of SUN2-AS1. (D) 293T cells were transfected with pcDNA3.1-GFP-HA (vector control), SUN2-HA (positive control), pcDNA3.1-HA-SUN2-AS1, or pcDNA3.1-SUN2-AS1-HA plasmid. At 36 h post- transfection, cells were harvested for a Western blot analysis to detect anti-HA bands. Blots were representative of at three independent experiments. (E) The relative expression of human β-actin (cytoplasmic control), U6 (nuclear control), and the expression of SUN2-AS1 were analyzed by using qRT-PCR in the nuclear and cytoplasmic fractions.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Synthesized, Clone Assay, Plasmid Preparation, Infection, Reverse Transcription, Amplification, Transfection, Control, Positive Control, Western Blot, Expressing, Quantitative RT-PCR

Fig. 2. Differential expression of SUN2-AS1 induced by various viruses. (A) A549 cells were infected with ZIKV at MOI 3, and total RNAs were harvested at indicated time points (0, 6, 12, 18, and 24 h.p.i.) to detect the SUN2-AS1 level by qRT-PCR (n = 5). (B) A549 cells were infected with ZIKV at indicated MOI (0, 0.05, 0.5, 5, and 10), and total RNAs were harvested at 24 h.p.i. to detect the SUN2-AS1 level by qRT-PCR (n = 5). (C) A549 cells were infected with ZIKV, DENV2 NGC, JEV, VSV, or HSV-1 (MOI 3), and total RNAs were harvested at 24 h.p.i. to detect the SUN2-AS1 level by qRT-PCR (n = 5). (D) A549, Huh7, LN229, hMDM (monocyte-differentiated macrophages), or 293T cells were infected with ZIKV at MOI 3 and harvested for total RNA extraction at 24 h.p.i. qRT-PCR was performed to detect the level of SUN2-AS1. Human U6 level was measured as an internal control and normalized to uninfected cells (MOI 0, 0 h, or wt A549) (n = 3). Bio logically independent experiments were conducted. Data were shown as means ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NS, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 2. Differential expression of SUN2-AS1 induced by various viruses. (A) A549 cells were infected with ZIKV at MOI 3, and total RNAs were harvested at indicated time points (0, 6, 12, 18, and 24 h.p.i.) to detect the SUN2-AS1 level by qRT-PCR (n = 5). (B) A549 cells were infected with ZIKV at indicated MOI (0, 0.05, 0.5, 5, and 10), and total RNAs were harvested at 24 h.p.i. to detect the SUN2-AS1 level by qRT-PCR (n = 5). (C) A549 cells were infected with ZIKV, DENV2 NGC, JEV, VSV, or HSV-1 (MOI 3), and total RNAs were harvested at 24 h.p.i. to detect the SUN2-AS1 level by qRT-PCR (n = 5). (D) A549, Huh7, LN229, hMDM (monocyte-differentiated macrophages), or 293T cells were infected with ZIKV at MOI 3 and harvested for total RNA extraction at 24 h.p.i. qRT-PCR was performed to detect the level of SUN2-AS1. Human U6 level was measured as an internal control and normalized to uninfected cells (MOI 0, 0 h, or wt A549) (n = 3). Bio logically independent experiments were conducted. Data were shown as means ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NS, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Quantitative Proteomics, Infection, Quantitative RT-PCR, RNA Extraction, Control

Fig. 3. SUN2-AS1 is an inducible host lncRNA through the type I IFN pathway. (A) 293T cells were transfected with varying amounts of cellular RNA (without ZIKV infection) or viral RNA cocktail (from 0 to 1 μg), which was extracted by the QIAamp Viral RNA Mini Kit. The levels of SUN2-AS1 were determined by qRT-PCR at 24 h post-transfection (n = 5). (B) 293T cells were transfected with various plasmids encoding Zika virus nonstructural proteins (1.0 μg). The levels of SUN2-AS1 were determined by qRT-PCR at 24 h post-transfection. (C) A549 cells were treated with 400 ng/ml poly(I:C), and the total cells were collected at indicated time points for RNA extraction to detect the level of SUN2-AS1 using qRT-PCR. (D) A549 cells were treated with 500 units/mL of IFN-β for 24 h and total RNAs were harvested to determine the level of SUN2-AS1 by qRT-PCR. (E) Putative transcription factor binding sites on the promoter region of SUN2-AS1. (F-G) RNA Immunoprecipitation (RIP) was performed on A549 cells using NF-κB and STAT1 antibodies. qRT-PCR analysis for SUN2-AS1, NKILA (binding to NF-κB p65) (F), and LUCAT1 (binding to STAT1) (G) expression in A549 (n = 3). (H–L) Control cells, IFNAR1KO or STAT1KO cells were treated with 500 units/mL of IFN-β for 24 h. Cell lysates were collected for Western blot to detect the phospho-STAT1, STAT1 and MX1 protein level (H for IFNAR1KO cells, and I for STAT1KO cells). Total RNAs were harvested to determine the level of IFNB1, ISG15 and MX1 by qRT-PCR (J-L). (M) A549 control cells, IFNAR1KO cells, or STAT1KO cells were infected with mock or ZIKV (MOI 3). Total RNAs were harvested at 24 h.p.i. to detect the level of SUN2-AS1 by qRT-PCR. Human U6 level was measured as an internal control and normalized to uninfected cells. Biologically independent experiments were conducted. Data were shown as means ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001. NS, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 3. SUN2-AS1 is an inducible host lncRNA through the type I IFN pathway. (A) 293T cells were transfected with varying amounts of cellular RNA (without ZIKV infection) or viral RNA cocktail (from 0 to 1 μg), which was extracted by the QIAamp Viral RNA Mini Kit. The levels of SUN2-AS1 were determined by qRT-PCR at 24 h post-transfection (n = 5). (B) 293T cells were transfected with various plasmids encoding Zika virus nonstructural proteins (1.0 μg). The levels of SUN2-AS1 were determined by qRT-PCR at 24 h post-transfection. (C) A549 cells were treated with 400 ng/ml poly(I:C), and the total cells were collected at indicated time points for RNA extraction to detect the level of SUN2-AS1 using qRT-PCR. (D) A549 cells were treated with 500 units/mL of IFN-β for 24 h and total RNAs were harvested to determine the level of SUN2-AS1 by qRT-PCR. (E) Putative transcription factor binding sites on the promoter region of SUN2-AS1. (F-G) RNA Immunoprecipitation (RIP) was performed on A549 cells using NF-κB and STAT1 antibodies. qRT-PCR analysis for SUN2-AS1, NKILA (binding to NF-κB p65) (F), and LUCAT1 (binding to STAT1) (G) expression in A549 (n = 3). (H–L) Control cells, IFNAR1KO or STAT1KO cells were treated with 500 units/mL of IFN-β for 24 h. Cell lysates were collected for Western blot to detect the phospho-STAT1, STAT1 and MX1 protein level (H for IFNAR1KO cells, and I for STAT1KO cells). Total RNAs were harvested to determine the level of IFNB1, ISG15 and MX1 by qRT-PCR (J-L). (M) A549 control cells, IFNAR1KO cells, or STAT1KO cells were infected with mock or ZIKV (MOI 3). Total RNAs were harvested at 24 h.p.i. to detect the level of SUN2-AS1 by qRT-PCR. Human U6 level was measured as an internal control and normalized to uninfected cells. Biologically independent experiments were conducted. Data were shown as means ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001. NS, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Transfection, Infection, Quantitative RT-PCR, Virus, RNA Extraction, Binding Assay, RNA Immunoprecipitation, Expressing, Control, Western Blot

Fig. 4. SUN2-AS1 promotes ZIKV replication. (A) Two SUN2-AS1 knockout A549 cells were generated by CRISPR/Cas9 technology. The knockout effects of SUN2- AS1 were determined by qRT-PCR under both mock and ZIKV infection. (B) Cell viability of control, SUN2-AS1KO-1, and SUN2-AS1KO-2 cells was determined by CCK8 with or without ZIKV infection at 24 h. (C-E) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 24 h. The viral RNA was extracted by QIAamp Viral RNA Mini Kit to detect the ZIKV RNA level by qRT-PCR (C). The cells and supernatants were harvested for Western blot (D) and plaque assay (E). (F) The pcDNA3.1 plasmid (empty vector) or pcDNA3.1-HA-SUN2-AS1 plasmid (1.0 μg) (SUN2-AS1OE) was transfected into A549 cells followed by infection with mock or ZIKV (MOI 3) for 24 h. Cells were harvested at 24 h.p.i., and the expression levels of SUN2-AS1 were determined by qRT-PCR. (G) Cell viability of pcDNA3.1 and SUN2-AS1OE cells was determined by CCK8 with or without ZIKV infection at 24 h. (H-J) pcDNA3.1 and SUN2-AS1OE cells were infected with ZIKV at MOI 3 for 24 h. The viral RNA level (H), E protein level (I), and titers of ZIKV particles (J) were measured by qRT-PCR, Western blot, and plaque assay, respectively. Human β-actin level was measured as an internal control and normalized to uninfected cells. All experiments were independently repeated three times. Data were shown as means ± S.D. *P < 0.1; ***P < 0.001; NS, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 4. SUN2-AS1 promotes ZIKV replication. (A) Two SUN2-AS1 knockout A549 cells were generated by CRISPR/Cas9 technology. The knockout effects of SUN2- AS1 were determined by qRT-PCR under both mock and ZIKV infection. (B) Cell viability of control, SUN2-AS1KO-1, and SUN2-AS1KO-2 cells was determined by CCK8 with or without ZIKV infection at 24 h. (C-E) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 24 h. The viral RNA was extracted by QIAamp Viral RNA Mini Kit to detect the ZIKV RNA level by qRT-PCR (C). The cells and supernatants were harvested for Western blot (D) and plaque assay (E). (F) The pcDNA3.1 plasmid (empty vector) or pcDNA3.1-HA-SUN2-AS1 plasmid (1.0 μg) (SUN2-AS1OE) was transfected into A549 cells followed by infection with mock or ZIKV (MOI 3) for 24 h. Cells were harvested at 24 h.p.i., and the expression levels of SUN2-AS1 were determined by qRT-PCR. (G) Cell viability of pcDNA3.1 and SUN2-AS1OE cells was determined by CCK8 with or without ZIKV infection at 24 h. (H-J) pcDNA3.1 and SUN2-AS1OE cells were infected with ZIKV at MOI 3 for 24 h. The viral RNA level (H), E protein level (I), and titers of ZIKV particles (J) were measured by qRT-PCR, Western blot, and plaque assay, respectively. Human β-actin level was measured as an internal control and normalized to uninfected cells. All experiments were independently repeated three times. Data were shown as means ± S.D. *P < 0.1; ***P < 0.001; NS, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Knock-Out, Generated, CRISPR, Quantitative RT-PCR, Infection, Control, Western Blot, Plaque Assay, Plasmid Preparation, Transfection, Expressing

Fig. 5. SUN2-AS1 is indispensable for flavivirus infection. (A-B) Control and SUN2-AS1KO cells were infected with DENV2 NGC (A) or JEV (B) (MOI = 5). The supernatant was collected at 24 h.p.i. The viral titers were determined using the focus-forming assay (FFA). (C-D) Vector control (pcDNA3.1) and SUN2-AS1OE cells were infected with DENV2 NGC (C) or JEV (D) (MOI = 5). The supernatant was collected at 24 h.p.i. and the viral titers were determined by focus forming assay (FFA). (E-F) Control and SUN2-AS1KO cells were infected with VSV (MOI = 1) or HSV-1 (MOI = 1). The supernatant of VSV (E) and HSV-1 (F) was collected at 24 h.p. i. and the viral titers were determined by the plaque-forming assay. All experiments were independently repeated three times. The data were shown as means ± S.D. *p ≤0.1; **p ≤0.01; NS, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 5. SUN2-AS1 is indispensable for flavivirus infection. (A-B) Control and SUN2-AS1KO cells were infected with DENV2 NGC (A) or JEV (B) (MOI = 5). The supernatant was collected at 24 h.p.i. The viral titers were determined using the focus-forming assay (FFA). (C-D) Vector control (pcDNA3.1) and SUN2-AS1OE cells were infected with DENV2 NGC (C) or JEV (D) (MOI = 5). The supernatant was collected at 24 h.p.i. and the viral titers were determined by focus forming assay (FFA). (E-F) Control and SUN2-AS1KO cells were infected with VSV (MOI = 1) or HSV-1 (MOI = 1). The supernatant of VSV (E) and HSV-1 (F) was collected at 24 h.p. i. and the viral titers were determined by the plaque-forming assay. All experiments were independently repeated three times. The data were shown as means ± S.D. *p ≤0.1; **p ≤0.01; NS, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Infection, Control, Focus Forming Assay, Plasmid Preparation

Fig. 6. SUN2-AS1 inhibits the expression of ISGs via regulating the transcription of ISGs mRNA. (A) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 24 h. Total cellular RNA was extracted by TRIzol to detect the mRNA level of IFNβ (A), ISG15 (B), MX1 (C), PKR (D), or OASL (E) by qRT-PCR. Human β-actin level was measured as an internal control and normalized to uninfected cells. (F-J) mRNA stability assay. Control and SUN2-AS1KO cells were treated with actinomycin D for 0, 3, 6, and 9 h. Cellular RNAs were extracted for qRT-PCR to measure the mRNA levels of GAPDH (F), ISG15 (G), MX1 (H), PKR (I), or OASL (J). Human β-actin level was measured as an internal control and normalized to untreated cells. Biologically independent experiments (n = 3) were conducted, and all data are shown as means ± S.D. P-values were calculated by one-way ANOVA. **P < 0.01, ***P < 0.001; ns, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 6. SUN2-AS1 inhibits the expression of ISGs via regulating the transcription of ISGs mRNA. (A) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 24 h. Total cellular RNA was extracted by TRIzol to detect the mRNA level of IFNβ (A), ISG15 (B), MX1 (C), PKR (D), or OASL (E) by qRT-PCR. Human β-actin level was measured as an internal control and normalized to uninfected cells. (F-J) mRNA stability assay. Control and SUN2-AS1KO cells were treated with actinomycin D for 0, 3, 6, and 9 h. Cellular RNAs were extracted for qRT-PCR to measure the mRNA levels of GAPDH (F), ISG15 (G), MX1 (H), PKR (I), or OASL (J). Human β-actin level was measured as an internal control and normalized to untreated cells. Biologically independent experiments (n = 3) were conducted, and all data are shown as means ± S.D. P-values were calculated by one-way ANOVA. **P < 0.01, ***P < 0.001; ns, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Expressing, Control, Infection, Quantitative RT-PCR, Stability Assay

Fig. 7. The proviral role of SUN2-AS1 is mediated by suppressing ISGs. (A) Cytotoxic effect of DMSO and Ruxolitinib in control or SUN2-AS1KO cells was determined by CCK8. (B-E) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 1 h. Then treated with 1 μM ruxolitinib. Cellular RNAs were extracted for qRT-PCR to measure the mRNA levels of ISG15 (B), MX1 (C), PKR (D), or OASL (E). Human β-actin level was measured as an internal control and normalized to uninfected cells. (F-H) Control and SUN2-AS1KO cells were infected with ZIKV (MOI = 3). Then treated with 1 μM ruxolitinib for 24 h. ZIKV RNA was extracted by the QIAamp Viral RNA Mini Kit and determine by qRT-PCR (F). Cell lysates were collected for Western blot to detect the MX1, PKR and ZIKV E protein level (G). And the supernatants were collected at 24 h.p.i for plaque assay (H). Biologically independent experiments (n = 3) were conducted, and all data are shown as means ± S.D. P-values were calculated by one-way ANOVA. *P < 0.1, **P < 0.01, ***P < 0.001; ns, not significant.

Journal: Virology

Article Title: Long non-coding RNA SUN2-AS1 acts as a negative regulator of ISGs transcription to promote flavivirus infection.

doi: 10.1016/j.virol.2024.110245

Figure Lengend Snippet: Fig. 7. The proviral role of SUN2-AS1 is mediated by suppressing ISGs. (A) Cytotoxic effect of DMSO and Ruxolitinib in control or SUN2-AS1KO cells was determined by CCK8. (B-E) Control and SUN2-AS1KO cells were infected with ZIKV at an MOI of 3 for 1 h. Then treated with 1 μM ruxolitinib. Cellular RNAs were extracted for qRT-PCR to measure the mRNA levels of ISG15 (B), MX1 (C), PKR (D), or OASL (E). Human β-actin level was measured as an internal control and normalized to uninfected cells. (F-H) Control and SUN2-AS1KO cells were infected with ZIKV (MOI = 3). Then treated with 1 μM ruxolitinib for 24 h. ZIKV RNA was extracted by the QIAamp Viral RNA Mini Kit and determine by qRT-PCR (F). Cell lysates were collected for Western blot to detect the MX1, PKR and ZIKV E protein level (G). And the supernatants were collected at 24 h.p.i for plaque assay (H). Biologically independent experiments (n = 3) were conducted, and all data are shown as means ± S.D. P-values were calculated by one-way ANOVA. *P < 0.1, **P < 0.01, ***P < 0.001; ns, not significant.

Article Snippet: The primary antibodies used in this study were as follows: Rabbit polyclonal antibodies against ZIKV E (GeneTex, GTX133314), rabbit polyclonal antibodies against SUN2 (Proteintech, 27556-1-AP), anti-phospho-STAT1 (HUABIO, ET1611-20), anti-STAT1 (HUABIO, ET1612-22), anti-MX1 (Proteintech, 13750-1-AP), anti-PKR (Proteintech, 18244-1-AP), anti-HA-tag mAb (MBL, M180-3) and rabbit polyclonal antibodies against GAPDH (Proteintech, I0494-I-AP).

Techniques: Control, Infection, Quantitative RT-PCR, Western Blot, Plaque Assay

Figure 6. Working model for the regulation of the Golgi organization by LINC complex. Left, The minus-end- directed MT motor activity, i.e., dynein (blue), dominates plus-end-directed motor activity under a steady-state condition, and juxtanuclear accumulation of the Golgi complex is observed. Right, In SUN1-depleted cells, KIF20A is activated or suppression of KIF20A activity is cancelled, and KIF20A activity dominates dynein activity. An explanation for the inhibition of KIF20A activity in the presence of SUN1 is that LINC complex formations are biased towards SUN1 inclusion and SUN2/nesprin-2 LINC complex formation is suppressed. In response to SUN1 depletion, incorporation of nesprin-2 in the SUN1-LINC complex decreased and SUN2/ nesprin-2 LINC complexes are formed. As a result, functions of KIF20A acting with a SUN2/nesprin-2 LINC complex becomes predominant (orange) over the minus-end-directed motor activities (blue), and the Golgi complex is dispersed.

Journal: Scientific reports

Article Title: The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal.

doi: 10.1038/s41598-021-84750-4

Figure Lengend Snippet: Figure 6. Working model for the regulation of the Golgi organization by LINC complex. Left, The minus-end- directed MT motor activity, i.e., dynein (blue), dominates plus-end-directed motor activity under a steady-state condition, and juxtanuclear accumulation of the Golgi complex is observed. Right, In SUN1-depleted cells, KIF20A is activated or suppression of KIF20A activity is cancelled, and KIF20A activity dominates dynein activity. An explanation for the inhibition of KIF20A activity in the presence of SUN1 is that LINC complex formations are biased towards SUN1 inclusion and SUN2/nesprin-2 LINC complex formation is suppressed. In response to SUN1 depletion, incorporation of nesprin-2 in the SUN1-LINC complex decreased and SUN2/ nesprin-2 LINC complexes are formed. As a result, functions of KIF20A acting with a SUN2/nesprin-2 LINC complex becomes predominant (orange) over the minus-end-directed motor activities (blue), and the Golgi complex is dispersed.

Article Snippet: Myc-tagged mouse SUN1 encoding 913 amino acids (NM_024451) and Myc-tagged mouse SUN2 were purchased from Origene (Rockville, MD, USA).

Techniques: Activity Assay, Inhibition

SUN2 oligomerization in the NE. (A) Constructs used in this figure. (B) Represent­ative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–E) Plots of b vs. N for the indicated constructs. The data in C were fitted to a monomer/dimer/trimer binding model (solid red line), which is shown in D and E (dashed red line), with K MD = 4100 (1000 μM) , K DT = 0.06 (0.01 μM) , and a monomer/trimer binding model (solid green line) with K MT = 26 (6 μM) ± 7.

Journal: Molecular Biology of the Cell

Article Title: Fluorescence fluctuation spectroscopy reveals differential SUN protein oligomerization in living cells

doi: 10.1091/mbc.E17-04-0233

Figure Lengend Snippet: SUN2 oligomerization in the NE. (A) Constructs used in this figure. (B) Represent­ative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–E) Plots of b vs. N for the indicated constructs. The data in C were fitted to a monomer/dimer/trimer binding model (solid red line), which is shown in D and E (dashed red line), with K MD = 4100 (1000 μM) , K DT = 0.06 (0.01 μM) , and a monomer/trimer binding model (solid green line) with K MT = 26 (6 μM) ± 7.

Article Snippet: NC (TR30015), SUN1 (TF300647B/FI302582), and SUN2 (TF300646A/FI302577) HuSH-29 shRNA constructs in pRFP-C-RS were purchased from OriGene Technologies).

Techniques: Construct, Expressing, Binding Assay

SUN1 and SUN2 oligomerization in the cytoplasm. (A) Constructs used in this figure. (B) Representative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–G) Plots of b vs. N for the indicated constructs. The data in C were fitted to a trimeric binding model (solid blue line), which is shown in D and E (dashed blue line) with K MD = 8000 (60 μM) ± 4000 and K DT = 0.3 (0.002 μM) ± 0.2. The data in F were fitted to a monomer/trimer/hexamer binding model (solid blue line) with K MT = 100 (0.7 μM) ± 60 and a trimer–hexamer dissociation coefficient K TH = 1500 (10 μM) ± 400, which is then shown in G (dashed blue line). Estimated binding curves (dashed red lines) for the data obtained in the NE for the indicated constructs are presented in C and F by converting N from the NE to its cytoplasmic value.

Journal: Molecular Biology of the Cell

Article Title: Fluorescence fluctuation spectroscopy reveals differential SUN protein oligomerization in living cells

doi: 10.1091/mbc.E17-04-0233

Figure Lengend Snippet: SUN1 and SUN2 oligomerization in the cytoplasm. (A) Constructs used in this figure. (B) Representative epifluorescence images of U2OS cells expressing the indicated constructs. Scale bar: 5 μm. (C–G) Plots of b vs. N for the indicated constructs. The data in C were fitted to a trimeric binding model (solid blue line), which is shown in D and E (dashed blue line) with K MD = 8000 (60 μM) ± 4000 and K DT = 0.3 (0.002 μM) ± 0.2. The data in F were fitted to a monomer/trimer/hexamer binding model (solid blue line) with K MT = 100 (0.7 μM) ± 60 and a trimer–hexamer dissociation coefficient K TH = 1500 (10 μM) ± 400, which is then shown in G (dashed blue line). Estimated binding curves (dashed red lines) for the data obtained in the NE for the indicated constructs are presented in C and F by converting N from the NE to its cytoplasmic value.

Article Snippet: NC (TR30015), SUN1 (TF300647B/FI302582), and SUN2 (TF300646A/FI302577) HuSH-29 shRNA constructs in pRFP-C-RS were purchased from OriGene Technologies).

Techniques: Construct, Expressing, Binding Assay

Models of SUN1 and SUN2 oligomerization. (A) Working model of SUN2 oligomerization. (B’ and B’’) Working models of SUN1 oligomerization with the NE, which lead to the assembly of higher-order SUN1 oligomers (SUN1 N ).

Journal: Molecular Biology of the Cell

Article Title: Fluorescence fluctuation spectroscopy reveals differential SUN protein oligomerization in living cells

doi: 10.1091/mbc.E17-04-0233

Figure Lengend Snippet: Models of SUN1 and SUN2 oligomerization. (A) Working model of SUN2 oligomerization. (B’ and B’’) Working models of SUN1 oligomerization with the NE, which lead to the assembly of higher-order SUN1 oligomers (SUN1 N ).

Article Snippet: NC (TR30015), SUN1 (TF300647B/FI302582), and SUN2 (TF300646A/FI302577) HuSH-29 shRNA constructs in pRFP-C-RS were purchased from OriGene Technologies).

Techniques:

Primers used to generate the constructs used in this paper.

Journal: Molecular Biology of the Cell

Article Title: Fluorescence fluctuation spectroscopy reveals differential SUN protein oligomerization in living cells

doi: 10.1091/mbc.E17-04-0233

Figure Lengend Snippet: Primers used to generate the constructs used in this paper.

Article Snippet: NC (TR30015), SUN1 (TF300647B/FI302582), and SUN2 (TF300646A/FI302577) HuSH-29 shRNA constructs in pRFP-C-RS were purchased from OriGene Technologies).

Techniques: Construct, Sequencing

( A ) Protein expression of DNAJB1-PRKACA (DP) is detected with a protein kinase A catalytic α subunit (PKA) antibody. WT PKAc, DP major, and DP minor are identified. Lane 1, FLC-H cell line; lane 2, nonmalignant liver; lane 3, FLC patient sample; lane 4, FLC PDX sample. Vinculin expression for loading control is shown in the lower panel. Uncropped immunoblot shown in , A and B. ( B ) qPCR showing the RQV of miR-10b in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA or scrambled sequence compared with mock ( n = 4 each condition). ( C ) Luciferase signal (RLU) in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment is shown as RQV compared with the scrambled negative control (6 trials, n = 6 each condition). ( D ) qPCR showing the RQV of FANCC , KLF11 , SEC14L2 , SIRT5 , SUN2 , and TRIM35 in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment compared with the negative control ( n = 5–7 trials with 3 replicates for each condition, SIRT5 n = 2 trials). ( E ) Soft agar colony formation of FLC-H cells 35 days after 500 nM miR-10b LNA compared with the negative control shown as RQV. ( F ) Representative nitro blue tetrazolium–stained images shown (2 trials, n = 8 each condition). ( G ) EdU incorporation in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA compared with the negative control shown as RQV (2 trials, n = 6 each condition). ( H ) Representative DAPI- and EdU-stained images show total and proliferative cells, respectively. Scale bars: 100 μm. In all assays, each dot represents the average signal across technical replicates for a single biological replicate. P values are calculated by 2-tailed Student’s t test. P values reported in B and D were adjusted for multiple testing correction post hoc by the Benjamini-Hochberg method.

Journal: JCI Insight

Article Title: Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma

doi: 10.1172/jci.insight.154743

Figure Lengend Snippet: ( A ) Protein expression of DNAJB1-PRKACA (DP) is detected with a protein kinase A catalytic α subunit (PKA) antibody. WT PKAc, DP major, and DP minor are identified. Lane 1, FLC-H cell line; lane 2, nonmalignant liver; lane 3, FLC patient sample; lane 4, FLC PDX sample. Vinculin expression for loading control is shown in the lower panel. Uncropped immunoblot shown in , A and B. ( B ) qPCR showing the RQV of miR-10b in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA or scrambled sequence compared with mock ( n = 4 each condition). ( C ) Luciferase signal (RLU) in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment is shown as RQV compared with the scrambled negative control (6 trials, n = 6 each condition). ( D ) qPCR showing the RQV of FANCC , KLF11 , SEC14L2 , SIRT5 , SUN2 , and TRIM35 in FLC-H cells after 6 days of 500 nM miR-10b LNA treatment compared with the negative control ( n = 5–7 trials with 3 replicates for each condition, SIRT5 n = 2 trials). ( E ) Soft agar colony formation of FLC-H cells 35 days after 500 nM miR-10b LNA compared with the negative control shown as RQV. ( F ) Representative nitro blue tetrazolium–stained images shown (2 trials, n = 8 each condition). ( G ) EdU incorporation in FLC-H cells 6 days after 500 nM treatment with miR-10b LNA compared with the negative control shown as RQV (2 trials, n = 6 each condition). ( H ) Representative DAPI- and EdU-stained images show total and proliferative cells, respectively. Scale bars: 100 μm. In all assays, each dot represents the average signal across technical replicates for a single biological replicate. P values are calculated by 2-tailed Student’s t test. P values reported in B and D were adjusted for multiple testing correction post hoc by the Benjamini-Hochberg method.

Article Snippet: Individual gene assay IDs include the following: CDH1, hs01023895; DNAJB1-PRKACA, custom; FANCC, hs0098454; KLF11, hs00231614; miR-10b, 002218; miR-21, 000397; miR-182, 002334; PTEN, hs02621230; RNU6, 001973; RPS9, hs02339424; SEC14L2, hs00391446; SIRT5, hs00978331; SUN2, hs00391446; and TRIM35, hs00324633 (Thermo Fisher Scientific).

Techniques: Expressing, Control, Western Blot, Sequencing, Luciferase, Negative Control, Staining

The LINC complex is absent from chromatin hernia. Representative images of U2OS GFP-NLS shLmnB1 cells arrested with thymidine, fixed, and labeled with LmnA antibodies (top three rows, rabbit; bottom, mouse) and (from top to bottom) Sun1, Sun2, nesprin1 (Nsp1), and nesprin2 (Nsp2) antibodies. Bars, 10 µm.

Journal: The Journal of Cell Biology

Article Title: Nuclear envelope rupture is induced by actin-based nucleus confinement

doi: 10.1083/jcb.201603053

Figure Lengend Snippet: The LINC complex is absent from chromatin hernia. Representative images of U2OS GFP-NLS shLmnB1 cells arrested with thymidine, fixed, and labeled with LmnA antibodies (top three rows, rabbit; bottom, mouse) and (from top to bottom) Sun1, Sun2, nesprin1 (Nsp1), and nesprin2 (Nsp2) antibodies. Bars, 10 µm.

Article Snippet: Antibodies used for immunoblotting were as follows: mouse antitubulin (1:5,000; Sigma-Aldrich), mouse anti-GAPDH (1:5,000; Genetex), rabbit anti-Sun1 (1:1,000; Novus Biologicals), and rabbit anti-Sun2 (1:1,000; Genetex).

Techniques: Labeling